Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare topic
No spam. Unsubscribe anytime.
Family thanks community, describes St. Jude clinical trial success and launches nonprofit
Summary
Crystal Baldman shared her daughter Kristine’s multi-year medical journey from tumor discovery to enrollment in an SJ91 St. Jude clinical trial, described dramatic clinical improvement and announced a new nonprofit, Standing with Crystal, to support other families facing pediatric cancer.
During public comment, Crystal Baldman and her husband Ty introduced their family and recounted their daughter Kristine’s medical journey. Crystal described the discovery of a brain tumor after a 2019 injury, periodic MRIs through 2022, a May 2023 operation to remove the tumor when it began pressing on an optic nerve, and an emergency June 2024 surgery to place a permanent shunt to drain intracranial fluid.
After those interventions, the family sought further options and connected with St. Jude Children’s Research Hospital, which accepted Kristine into a clinical-trial program using SJ91, a targeted MEK-inhibitor therapy. Crystal said the treatment produced a ‘‘miraculous’’ response and that Kristine is now almost cancer-free while taking a daily oral regimen. The family announced a nonprofit, Standing with Crystal, to raise awareness and support other families; Crystal invited residents to follow the effort on Facebook.
Ending: The council thanked the family for sharing their story and the meeting moved on.
